40 likes | 93 Views
Description : FDA continues to enforce Part 11 through its new Part 11 inspection and enforcement program. Just in the last 3 years, FDA issued more than 30 warning letters with Part 11 violations. Citations are related to inadequate integrity, security and availability of electronic records but also related to validation of software and computer systems. There are many questions about Part 11 inspections, e.g., what inspectors are looking at what are major findings. The seminar will have the answers. In addition, using industry proven case studies on how to avoid 483 inspectional observations and warning letters attendees will learn how to prepare their organization for trouble-free Part 11 related inspections.
E N D
Contact Us:+1-248-233-2049 Product Code Category Date Duration Speaker GRC-90078 Medical 12th January 2017 | 01:00 PM EST 75Min Ludwig Huber To Register for this webinar please visit:https://www.grcts.com/GRC-90078. Webinar Description: FDA continues to enforce Part 11 through its new Part 11 inspection and enforcement program. Just in the last 3 years, FDA issued more than 30 warning letters with Part 11 violations. Citations are related to inadequate integrity, security and availability of electronic records but also related to validation of software and computer systems. There are many questions about Part 11 inspections, e.g., what inspectors are looking at what are major findings. The seminar will have the answers. In addition, using industry proven case studies on how to avoid 483 inspectional observations and warning letters attendees will learn how to prepare their organization for trouble-free Part 11 related inspections.
Areas Covered in the Session : FDA's current inspection and enforcement practices FDA's new interpretation: learning from FDA inspection reports Strategy for cost-effective implementation of Part 11: A six step plan Recommended changes to existing Part 11 programs to reduce costs Justification and documentation for the FDA and your management Going through case studies from laboratories, offices and manufacturing with graphical workflow of records, step-by-step description, recommendations for individual Part 11 requirements with justifications and documentation for the FDA and your management. Case studies how to avoid or respond to Part 11 related observations with corrective actions to fix current issues and preventive actions to prevent reoccurrence of the same or similar issues. How to prepare your company for Part 11 Inspections. Who will benefit : QC Managers QA Managers and Personnel IT Administrators Analysts Regulatory Affairs
Training Departments Documentation department Consultants. Speaker Profile: Ludwig Huber, Ph.D., is the director of Labcompliance and editor of www.labcompliance.com, the global online resource for validation and compliance. He is the author of the books "Validation and Qualification in Analytical Laboratories" and "Validation of Computerized Analytical and Networked Systems". He has given multiple presentations mainly on GLP/GMP, 21 CFR Part 11, and Validation around the world. This included seminars, workshops and presentations for the US FDA, China CFDA, , ISPE, Japan PDA, PIC/S and several other national health care agencies. Available Options: Live : For one participant $129 Corporate Offer 1 :Max 3 - 5 Participants $399
Corporate Offer 2:Max 10 Participants $599 Recorded Webinar:Get unlimited access to the link for six months $179 Get CD/DVD: $259 Super Combo Offer 1:For One partcipant Live and Recorded webinar Only! $309 Super Combo Offer 2:For One partcipant Live and Training CD Only! $349